Skip to content
Mountainside Medical is a Family-Owned, Service-Disabled Veteran Owned Small Business
⛰️ FREE SHIPPING ON ORDERS $100 OR MORE ⛰️ Toll Free: 1-888-687-4334

Isoniazid Oral Syrup 50mg/5mL - CMP Pharma 16 oz

Save 22%
Original price $ 699.95
Current price $ 545.00
SKU 46287-0009-01
Medical Professional License Required to Unlock Account

(Note: We don’t Fill Personal Prescriptions)


How to Order:

Create an Account by Clicking “Login” on Top Right

Next email a copy of medical License to Sales@mountainside-medical.com

Time: License Approval in Usually Very Fast. Mostly likely 30 to 90 minutes if between Monday to Friday 8 am to 4 pm EST Business Days. Weekends will be approved on Monday.

Once Approved you will receive a Welcome email that your account is approved to purchase RX items.

Login and Start ordering.

If you should have any trouble or have a question, Please Call Toll-Free: 1-888-687-4334

All RX Deliveries are sent Signature Required

Isoniazid Syrup 50mg/5mL is used with other medications to treat active tuberculosis (TB) infections. It is also used alone to prevent active TB infections in people who may be infected with the bacteria (people with positive TB skin test). Isoniazid is an antibiotic and works by stopping the growth of bacteria.This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Isoniazid is an antituberculosis drug; it has a bactericidal effect, inhibiting the synthesis of mycolid acids, which are an essential component of mycobacteria cellular membranes. It is especially active against proliferous microorganisms (including those located intracellularly).
Isoniazid has rarely caused very serious (possibly fatal) liver disease. The risk of liver disease is increased in people who are 35 years and older, who use alcohol or illegal injection drugs, or who currently have long-term liver problems. Tell your doctor right away if you develop symptoms of liver disease, including persistent nausea/vomiting, severe stomach/abdominal pain, unusual weakness/tiredness, dark urine, yellowing eyes/skin.Your doctor should order liver function tests while you are taking this medication. Keep all medical and laboratory appointments.

Isoniazid is recommended for all forms of tuberculosis in which organisms are susceptible. However, active tuberculosis must be treated with multiple concomitant antituberculosis medications to prevent the emergence of drug resistance. Single-drug treatment of active tuberculosis with isoniazid, or any other medication, is inadequate therapy.

Isoniazid is recommended as preventive therapy for the following groups, regardless of age. (Note: the criterion for a positive reaction to a skin test (in millimeters of induration) for each group is given in parenthesis):

  • Persons with human immunodeficiency virus (HIV) infection (≥ 5 mm) and persons with risk factors for HIV infection whose HIV infection status is unknown but who are suspected of having HIV infection. Preventive therapy may be considered for HIV infected persons who are tuberculin-negative but belong to groups in which the prevalence of tuberculosis infection is high. Candidates for preventive therapy who have HIV infection should have a minimum of 12 months of therapy.
  • Close contacts of persons with newly diagnosed infectious tuberculosis (≥ 5 mm). In addition, tuberculin-negative (< 5 mm) children and adolescents who have been close contacts of infectious persons within the past 3 months are candidates for preventive therapy until a repeat tuberculin skin test is done 12 weeks after contact with the infectious source. If the repeat skin test is positive (> 5 mm), therapy should be continued.
  • Recent converters, as indicated by a tuberculin skin test (≥ 10 mm increase within a two year period for those < 35 years old; ≥ 15 mm increase for those ≥ 35 years of age). All infants and children younger than 4 years of age with a > 10 mm skin test are included in this category.
  • Persons with abnormal chest radiographs that show fibrotic lesions likely to represent old healed tuberculosis (≥ 5 mm). Candidates for preventive therapy who have fibrotic pulmonary lesions consistent with healed tuberculosis or who have pulmonary silicosis should have 12 months of isoniazid or 4 months of isoniazid and rifampin, concomitantly.
  • Intravenous drug users known to be HIV-seronegative (> 10 mm).
  • Persons with the following medical conditions that have been reported to increase the risk of tuberculosis (≥ 10 mm): silicosis; diabetes mellitus; prolonged therapy with adrenocorticosteroids; immunosuppressive therapy; some hematologic and reticuloendothelial diseases, such as leukemia or Hodgkin’s disease; end-stage renal disease; clinical situations associated with substantial rapid weight loss or chronic undernutrition (including: intestinal bypass surgery for obesity, the postgastrectomy state (with or without weight loss), chronic peptic ulcer disease, chronic malabsorption syndromes, and carcinomas of the oropharynx and upper gastrointestinal tract that prevent adequate nutritional intake). Candidates for preventive therapy who have fibrotic pulmonary lesions consistent with healed tuberculosis or who have pulmonary silicosis should have 12 months of isoniazid or 4 months of isoniazid and rifampin, concomitantly.

Buy Isoniazid Syrup 50mg/5mL used to treat active tuberculosis (TB) infections online at Mountainside Medical Equipment.

Search Any Type of Product, Medication, or Alignment

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)